| Scrip Code | 543524 |
|---|---|
| NSE Symbol | RAINBOW |
| MSEI Symbol | NOTLISTED |
| ISIN | INE961O01016 |
| Name of company | Rainbow Childrens Medicare Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 23-05-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 15-05-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Fourth quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited |
| Segment Reporting | Single segment |
| Description of single segment | The business of running multi specialty pediatric and obstetrics and gynecology hospital. |
| Start date and time of board meeting | 23-05-2026 16:45:00 |
| End date and time of board meeting | 23-05-2026 18:30:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-01-2026 | 01-04-2025 |
| B | Date of end of reporting period | 31-03-2026 | 31-03-2026 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 45,990.10 | 1,70,307.70 | |
| Other income | 506.40 | 4,378.80 | |
| Total income | 46,496.50 | 1,74,686.50 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 5,698.30 | 22,702.90 |
| (b) | Purchases of stock-in-trade | 0.00 | 0.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0.00 | 0.00 |
| (d) | Employee benefit expense | 6,307.00 | 23,353.00 |
| (e) | Finance costs | 2,049.50 | 7,761.70 |
| (f) | Depreciation, depletion and amortisation expense | 4,094.20 | 15,057.00 |
| (f) | Other Expenses | ||
| 1 | Professional fees to doctors | 11,267.10 | 41,881.00 |
| 2 | Canteen expenses | 677.70 | 2,720.60 |
| 3 | Contract wages | 1,372.40 | 4,879.40 |
| 4 | Housekeeping expenses | 220.70 | 873.90 |
| 5 | Power and fuel | 652.10 | 2,884.60 |
| 6 | Lab and investigations | 460.80 | 1,673.00 |
| 7 | Repairs and maintenance | 823.70 | 3,431.50 |
| 8 | Rates and taxes | 586.40 | 1,980.20 |
| 9 | Business promotion and advertisement | 929.90 | 2,710.60 |
| 10 | Other Expenses | 2,523.70 | 6,800.30 |
| Total other expenses | 19,514.50 | 69,835.10 | |
| Total expenses | 37,663.50 | 1,38,709.70 | |
| 3 | Total profit before exceptional items and tax | 8,833.00 | 35,976.80 |
| 4 | Exceptional items | (153.90) | (153.90) |
| 5 | Total profit before tax | 8,679.10 | 35,822.90 |
| 6 | Tax expense | ||
| 7 | Current tax | 2,583.40 | 9,613.30 |
| 8 | Deferred tax | (1,726.10) | (1,944.80) |
| 9 | Total tax expenses | 857.30 | 7,668.50 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 7,821.80 | 28,154.40 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 7,821.80 | 28,154.40 |
| 17 | Other comprehensive income net of taxes | (67.20) | (71.70) |
| 18 | Total Comprehensive Income for the period | 7,754.60 | 28,082.70 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 7,704.30 | 27,832.30 | |
| Total profit or loss, attributable to non-controlling interests | 117.50 | 322.10 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | (65.40) | (71.20) | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | (1.70) | (0.50) | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 10,155.90 | 10,155.90 | |
| Face value of equity share capital | 10 | 10 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | 1,54,651.50 | |
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 7.59 | 27.41 | |
| Diluted earnings (loss) per share from continuing operations | 7.59 | 27.41 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 7.59 | 27.41 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 7.59 | 27.41 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | For notes please refer results page |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | ||
|---|---|---|---|
| Date of start of reporting period | 01-04-2025 | ||
| Date of end of reporting period | 31-03-2026 | ||
| Whether results are audited or unaudited | Audited | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Assets | |||
| 1 | Non-current assets | ||
| Property, plant and equipment | 1,56,161.20 | ||
| Capital work-in-progress | 7,575.10 | ||
| Investment property | 0.00 | ||
| Goodwill | 15,689.00 | ||
| Other intangible assets | 3,738.50 | ||
| Intangible assets under development | 347.00 | ||
| Biological assets other than bearer plants | 0.00 | ||
| Investments accounted for using equity method | 0.00 | ||
| Non-current financial assets | |||
| Non-current investments | 0.30 | ||
| Trade receivables, non-current | 0.00 | ||
| Loans, non-current | 2,750.10 | ||
| Other non-current financial assets | |||
| 1 | Other financial assets | 14,232.40 | |
| Total of other non-current financial assets | 14,232.40 | ||
| Total non-current financial assets | 16,982.80 | ||
| Deferred tax assets (net) | 5,007.00 | ||
| Other non-current assets | |||
| 1 | Non-current tax assets (net) | 1,582.30 | |
| 2 | Other non-current assets | 4,115.70 | |
| Total of other non-current assets | 5,698.00 | ||
| Total non-current assets | 2,11,198.60 | ||
| 2 | Current assets | ||
| Inventories | 4,163.40 | ||
| Current financial asset | |||
| Current investments | 40,449.50 | ||
| Trade receivables, current | 10,317.90 | ||
| Cash and cash equivalents | 3,389.40 | ||
| Bank balance other than cash and cash equivalents | 0.00 | ||
| Loans, current | 400.10 | ||
| Other current financial assets | |||
| Total of other current financial assets | 5,064.30 | ||
| Total current financial assets | 59,621.20 | ||
| Current tax assets (net) | |||
| Other current assets | |||
| 1 | Other current assets | 2,500.80 | |
| Total of other current assets | 2,500.80 | ||
| Total current assets | 66,285.40 | ||
| 3 | Non-current assets classified as held for sale | ||
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | ||
| Total assets | 2,77,484.00 | ||
| Equity and liabilities | |||
| 1 | Equity | ||
| Equity attributable to owners of parent | |||
| Equity share capital | 10,155.90 | ||
| Other equity | 1,54,651.50 | ||
| Total equity attributable to owners of parent | 1,64,807.40 | ||
| Non controlling interest | 1,551.40 | ||
| Total equity | 1,66,358.80 | ||
| 2 | Liabilities | ||
| Non-current liabilities | |||
| Non-current financial liabilities | |||
| Borrowings, non-current | 0.00 | ||
| Trade payables, non-current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | |||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | |||
| Total Trade payable | |||
| Other non-current financial liabilities | |||
| 1 | Lease liabilities | 86,536.90 | |
| 2 | Other non-current financial liabilities | 4,340.70 | |
| Total of other non-current financial liabilities | 90,877.60 | ||
| Total non-current financial liabilities | 90,877.60 | ||
| Provisions, non-current | 1,801.50 | ||
| Deferred tax liabilities (net) | 0.00 | ||
| Deferred government grants, Non-current | 0.00 | ||
| Other non-current liabilities | |||
| Total of other non-current liabilities | |||
| Total non-current liabilities | 92,679.10 | ||
| Current liabilities | |||
| Current financial liabilities | |||
| Borrowings, current | 0.00 | ||
| Trade payables, current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 2,958.90 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 7,097.90 | ||
| Total Trade payable | 10,056.80 | ||
| Other current financial liabilities | |||
| 1 | lease liabilities | 2,561.40 | |
| 2 | Other current financial liabilities | 2,596.50 | |
| Total of other current financial liabilities | 5,157.90 | ||
| Total current financial liabilities | 15,214.70 | ||
| Other current liabilities | 2,920.60 | ||
| 1 | Other current liabilities | 2,841.40 | |
| 2 | Deferred tax liabilities | 79.20 | |
| Total of other current liabilities | 2,920.60 | ||
| Provisions, current | 305.80 | ||
| Current tax liabilities (Net) | 5.00 | ||
| Deferred government grants, Current | |||
| Total current liabilities | 18,446.10 | ||
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | ||
| 4 | Regulatory deferral account credit balances and related deferred tax liability | ||
| Total liabilities | 1,11,125.20 | ||
| Total equity and liabilites | 2,77,484.00 | ||
| Disclosure of notes on assets and liabilities | Textual Information(1) | ||
| Textual Information(1) | For notes please refer results page |
|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-01-2026 | 01-04-2025 | |||||
| Date of end of reporting period | 31-03-2026 | 31-03-2026 | |||||
| Whether results are audited or unaudited | Audited | Audited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-01-2026 | 01-04-2025 |
| B | Date of end of reporting period | 31-03-2026 | 31-03-2026 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Re-measurement (loss)/gain on defined benefit obligation | (88.50) | (95.80) |
| Total Amount of items that will not be reclassified to profit and loss | (88.50) | (95.80) | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | (21.30) | (24.10) |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | ||
| 5 | Total Other comprehensive income | (67.20) | (71.70) |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2025 | ||||
| B | Date of end of reporting period | 31-03-2026 | ||||
| C | Whether results are audited or unaudited | Audited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 35,822.90 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 7,661.70 | |||||
| Adjustments for decrease (increase) in inventories | (1,406.50) | |||||
| Adjustments for decrease (increase) in trade receivables, current | (3,125.90) | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | (1,567.10) | |||||
| Adjustments for decrease (increase) in other non-current assets | 0.00 | |||||
| Adjustments for other financial assets, non-current | 0.00 | |||||
| Adjustments for other financial assets, current | 0.00 | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | 1,672.80 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | 0.00 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 15,057.00 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |||||
| Adjustments for provisions, current | 369.50 | |||||
| Adjustments for provisions, non-current | 0.00 | |||||
| Adjustments for other financial liabilities, current | 1,084.40 | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | (6.40) | |||||
| Adjustments for dividend income | 0.00 | |||||
| Adjustments for interest income | 0.00 | |||||
| Adjustments for share-based payments | 291.20 | |||||
| Adjustments for fair value losses (gains) | 0.00 | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | (2,468.20) | |||||
| Other adjustments to reconcile profit (loss) | 11.30 | |||||
| Other adjustments for non-cash items | (1,277.40) | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | 16,296.40 | |||||
| Net cash flows from (used in) operations | 52,119.30 | |||||
| Dividends received | 0.00 | |||||
| Interest paid | 0.00 | |||||
| Interest received | 0.00 | |||||
| Income taxes paid (refund) | 10,153.80 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | 41,965.50 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 20,319.30 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 128.90 | |||||
| Purchase of property, plant and equipment | 21,645.50 | |||||
| Proceeds from sales of investment property | 0.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 0.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 0.00 | |||||
| Interest received | 1,163.40 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 14,807.90 | |||||
| Net cash flows from (used in) investing activities | (25,864.60) | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 0.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 0.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 0.00 | |||||
| Repayments of borrowings | 0.00 | |||||
| Payments of lease liabilities | 1,799.90 | |||||
| Dividends paid | 3,046.50 | |||||
| Interest paid | 7,761.70 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | (2,128.90) | |||||
| Net cash flows from (used in) financing activities | (14,737.00) | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 1,363.90 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 0.00 | |||||
| Net increase (decrease) in cash and cash equivalents | 1,363.90 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 0.00 | |||||
| Cash and cash equivalents cash flow statement at end of period | 1,363.90 | |||||
| Whether results are audited or unaudited | Audited |
|---|---|
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | S.R. BATLIBOI & ASSOCIATES LLP | Yes | 31-07-2027 | ||
|---|---|---|---|---|---|